DaVita Healthcare Partners
A Denver jury awarded a monumental $383.5 million jury verdict against GranuFlo dialysis provider DaVita Inc. on June 27, 2018, to families of three patients who suffered cardiac arrests and died after receiving dialysis treatments at DaVita clinics. Read the press release »
If your family member or loved one died or was seriously harmed during dialysis at DaVita or shortly after the dialysis session, contact Hagens Berman now »
Hagens Berman's expert trial attorneys recently won a monumental $383.5 million jury verdict on behalf of three families of dialysis patients who died after receiving treatment from DaVita:
- Helped a Sacramento family’s four children recover for the death of their mother when she collapsed suddenly approximately two hours after receiving a GranuFlo treatment at DaVita, leaving her neurologically devastated and in a persistent vegetative state after a cardiac arrest. $2M in compensatory damages and $125M in punitive damages.
- Assisted an Illinois family with their case on behalf of 10 siblings whose mother was killed when she was supplied excess bicarbonate via GranuFlo without her doctor’s knowledge by her DaVita clinic. $5M in compensatory damages and $125M in punitive damages.
- Sued for an Arizona spouse and her children when their father was found unresponsive and pronounced dead following his GranuFlo treatment at DaVita. $1.5M in compensatory damages and $125M in punitive damages.
ABOUT THE CASE AGAINST DAVITA
Hagens Berman filed a series of lawsuits alleging that DaVita Healthcare Partners, Inc.’s actions led to the deaths of three dialysis patients. The lawsuits alleged the problems causing those deaths have impacted thousands of dialysis patients across the country.
The suits claim that DaVita – one of the nation’s largest providers of dialysis services – failed to recognize that one of the medical devices DaVita selected for use in DaVita dialysis clinics was causing dangerously high levels of bicarbonate in the patients and dangerous shifts in electrolytes, which the suit claims caused the deaths of the three patients mentioned in the suits, along with many other unreported deaths and cardiac arrests.
According to those lawsuits, DaVita used GranuFlo without disclosing the risks or using it properly. The product had the potential to cause severe, life-threatening reactions, including death, in certain patients. The suits seek to represent patients who suffered death, especially cardiac arrest. Hagens Berman is also evaluating other adverse events, including death by infection.
Patients, former patients, or their surviving families who believe they or their loved one suffered from cardiac arrest or another adverse event are encouraged to contact Hagens Berman attorneys. You can reach an attorney by calling 888-381-2889 or by filling out the form on this page.
The lawsuits claim that DaVita is guilty of concealment and negligence for failing to use the product properly and not following the instructions. DaVita owns and operates 1,954 outpatient dialysis centers in 44 states throughout the United States.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.